Basel Medical (BMGL) Depreciation & Amortization - Total (2023 - 2024)

Basel Medical recorded quarterly Depreciation & Amortization - Total of -$264226.1 in Q4 2024, down 34.55% quarter-over-quarter from -$196372.4 in Q4 2023, and down 34.55% year-over-year from -$403729.0 in Q1 2024.

Basel Medical's Depreciation & Amortization - Total history runs 2 years deep, the most recent figure standing at -$264226.1 for Q4 2024.

  • In Q4 2024, Depreciation & Amortization - Total fell 34.55% year-over-year to -$264226.1; the TTM figure through Jun 2025 stood at -$460598.5 (changed N/A YoY), while the FY2025 annual figure was $907397.1, up 132.19% from the prior year.
  • Depreciation & Amortization - Total came in at -$264226.1 for Q4 2024 at Basel Medical, down from -$196372.4 in the prior quarter.
  • In the past five years, Depreciation & Amortization - Total ranged from a high of -$196372.4 in Q4 2023 to a low of -$264226.1 in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Tot) (Qtr)
1 HCA Healthcare 84.64 Bn 87.02 Bn 16.26 Bn -
2 Tenet Healthcare 15.22 Bn 14.39 Bn 4.41 Bn -
3 Davita 13.10 Bn 13.96 Bn 1.07 Bn -
4 Encompass Health 10.50 Bn 11.12 Bn 1.34 Bn -
5 Ensign 9.69 Bn 9.09 Bn 293.37 Mn -
6 Universal Health Services 8.92 Bn 8.88 Bn 3.21 Bn -
7 Fresenius Medical Care AG 7.31 Bn 4.93 Bn 22,843.10 Bn -
8 Chemed 5.83 Bn 5.81 Bn 215.76 Mn 14.30 Mn
9 Pacs 5.76 Bn 5.51 Bn 345.96 Mn -
10 Basel Medical 8.57 Mn 6.23 Mn - -

Historic Data

Download Data 🔒
DateValue
Dec 31, 2024 -264,226.12
Dec 31, 2023 -196,372.38